Frequency of Hypoglycaemia after Different Bariatric Surgical Procedures.


Journal

Obesity facts
ISSN: 1662-4033
Titre abrégé: Obes Facts
Pays: Switzerland
ID NLM: 101469429

Informations de publication

Date de publication:
2019
Historique:
received: 05 10 2017
accepted: 14 09 2018
pubmed: 25 6 2019
medline: 12 2 2020
entrez: 25 6 2019
Statut: ppublish

Résumé

The frequency of postprandial hypoglycaemia after different operative procedures of bariatric surgery (BS) is unknown, although this complication is potentially dangerous. Predictors and severity of hypoglycaemia after Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy, and gastric banding were investigated in a large prospective study. This study was performed at an excellence centre for BS at a tertiary care institution. Data of 333 patients (mean BMI: 44.9 ± 9.6 kg/m2; mean age: 40 ± 10 years; 80.7% women) were analysed in a prospective study with a 2-year observation period after BS. All patients underwent a 2-hour oral glucose tolerance test (OGTT) with measurements of blood glucose (BG) and insulin. For the purpose of this study, hypoglycaemia was defined as a post-challenge BG <2.8 mmol/L during the OGTT. 72 (25.6%) of 281 patients showed post-challenge hypoglycaemia after surgery. Hypoglycaemia was different after various procedures: 32.6% of patients after RYGB, 22.6% after sleeve gastrectomy, but only 2.3% after gastric banding had hypoglycaemia. In the whole group, patients with hypoglycaemia had lost more weight (p = 0.013), had a slightly greater decrease in BMI (p = 0.037), a greater change in 2-hour post-challenge BG (p = 0.001), and a smaller change in 1-hour post-challenge insulin (p = 0.004) compared to patients without hypoglycaemia. This prospective study shows a higher prevalence of severe hypoglycaemia (25.6%) after BS than anticipated from retrospective registers. A systematic evaluation of glucose and insulin levels by OGTT 2 years post-surgery may help to identify patients at increased risk for symptomatic and asymptomatic hypoglycaemia.

Identifiants

pubmed: 31234171
pii: 000493735
doi: 10.1159/000493735
pmc: PMC6758723
doi:

Substances chimiques

Blood Glucose 0
Insulin 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

397-406

Informations de copyright

© 2019 The Author(s) Published by S. Karger AG, Basel.

Références

Lancet. 2012 Jun 16;379(9833):2300-11
pubmed: 22683132
Surg Obes Relat Dis. 2015 May-Jun;11(3):564-9
pubmed: 25737101
Surg Obes Relat Dis. 2015 May-Jun;11(3):573-7
pubmed: 25892342
Obes Surg. 2009 Nov;19(11):1550-6
pubmed: 19557485
N Engl J Med. 2005 Jul 21;353(3):249-54
pubmed: 16034010
Obes Surg. 2011 Jul;21(7):902-9
pubmed: 21347823
N Engl J Med. 2007 Aug 23;357(8):753-61
pubmed: 17715409
N Engl J Med. 2007 Aug 23;357(8):741-52
pubmed: 17715408
Obes Surg. 2009 Mar;19(3):274-80
pubmed: 19034589
J Clin Endocrinol Metab. 2007 Dec;92(12):4678-85
pubmed: 17895322
J Clin Endocrinol Metab. 2010 Mar;95(3):1069-75
pubmed: 20097707
Surg Endosc. 2011 Jun;25(6):1926-32
pubmed: 21184112
Diabetes Care. 2005 May;28(5):1245-9
pubmed: 15855602
Obesity (Silver Spring). 2015 May;23(5):1079-84
pubmed: 25866150
Diabetes Care. 2011 May;34 Suppl 2:S355-60
pubmed: 21525482
Eur J Endocrinol. 2015 Jul;173(1):91-100
pubmed: 25899582
Obes Surg. 2011 Jan;21(1):95-101
pubmed: 21088924
Obes Surg. 2008 Jul;18(7):833-40
pubmed: 18408982
Obes Surg. 2006 Sep;16(9):1214-20
pubmed: 16989707
Obes Surg. 2008 Oct;18(10):1251-6
pubmed: 18663545
Surg Obes Relat Dis. 2008 Jul-Aug;4(4):492-9
pubmed: 18656831
Gastroenterology. 2014 Mar;146(3):605-8
pubmed: 24468184
Diabetologia. 2010 Nov;53(11):2276-9
pubmed: 20730413
Obes Surg. 2012 Jan;22(1):23-8
pubmed: 21647622
Am J Epidemiol. 2000 Jan 15;151(2):190-8
pubmed: 10645822
Obes Surg. 2009 Nov;19(11):1515-21
pubmed: 19714384
Diabetes Care. 2011 May;34 Suppl 2:S132-7
pubmed: 21525444
Diabetologia. 2010 Nov;53(11):2307-11
pubmed: 20495972
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825

Auteurs

Johanna Maria Brix (JM)

Department of Medicine I, Rudolfstiftung Hospital Vienna, Vienna, Austria.
Karl Landsteiner Institute for Obesity and Metabolism, Vienna, Austria.

Hans-Peter Kopp (HP)

Department of Medicine I, Rudolfstiftung Hospital Vienna, Vienna, Austria.
Karl Landsteiner Institute for Obesity and Metabolism, Vienna, Austria.

Florian Höllerl (F)

Department of Medicine I, Rudolfstiftung Hospital Vienna, Vienna, Austria.
Karl Landsteiner Institute for Obesity and Metabolism, Vienna, Austria.

Gerit Holger Schernthaner (GH)

Division of Angiology, Department of Medicine II, Medical University of Vienna, Vienna, Austria.

Bernhard Ludvik (B)

Department of Medicine I, Rudolfstiftung Hospital Vienna, Vienna, Austria, bernhard.ludvik@wienkav.at.
Karl Landsteiner Institute for Obesity and Metabolism, Vienna, Austria, bernhard.ludvik@wienkav.at.

Guntram Schernthaner (G)

Department of Medicine I, Rudolfstiftung Hospital Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH